307 related articles for article (PubMed ID: 19535571)
21. Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.
Kong J; Kim GH; Wei M; Sun T; Li G; Liu SQ; Li X; Bhan I; Zhao Q; Thadhani R; Li YC
Am J Pathol; 2010 Aug; 177(2):622-31. PubMed ID: 20616348
[TBL] [Abstract][Full Text] [Related]
22. Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin.
Zhang Y; Diao TY; Gu SS; Wu SY; Gebru YA; Chen X; Wang JY; Ran S; Wong MS
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):218-27. PubMed ID: 23283823
[TBL] [Abstract][Full Text] [Related]
23. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D receptor signaling in podocytes protects against diabetic nephropathy.
Wang Y; Deb DK; Zhang Z; Sun T; Liu W; Yoon D; Kong J; Chen Y; Chang A; Li YC
J Am Soc Nephrol; 2012 Dec; 23(12):1977-86. PubMed ID: 23123403
[TBL] [Abstract][Full Text] [Related]
25. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
[TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
Hayashi K; Sasamura H; Nakamura M; Sakamaki Y; Azegami T; Oguchi H; Tokuyama H; Wakino S; Hayashi K; Itoh H
Kidney Int; 2015 Oct; 88(4):745-53. PubMed ID: 26108068
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
28. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
29. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
Zimpelmann J; Kumar D; Levine DZ; Wehbi G; Imig JD; Navar LG; Burns KD
Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066
[TBL] [Abstract][Full Text] [Related]
30. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
[TBL] [Abstract][Full Text] [Related]
31. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.
Komers R; Oyama TT; Beard DR; Tikellis C; Xu B; Lotspeich DF; Anderson S
Kidney Int; 2011 Feb; 79(4):432-42. PubMed ID: 20962741
[TBL] [Abstract][Full Text] [Related]
32. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
[TBL] [Abstract][Full Text] [Related]
33. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
[TBL] [Abstract][Full Text] [Related]
34. Effects of angiotensin receptor blocker on oxidative stress and cardio-renal function in streptozotocin-induced diabetic rats.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Suzuki K; Tachikawa H; Kodama M; Aizawa Y
Biol Pharm Bull; 2009 Aug; 32(8):1411-6. PubMed ID: 19652382
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
Pan Y; Huang Y; Wang Z; Fang Q; Sun Y; Tong C; Peng K; Wang Y; Miao L; Cai L; Zhao Y; Liang G
J Cell Mol Med; 2014 Feb; 18(2):231-41. PubMed ID: 24330074
[TBL] [Abstract][Full Text] [Related]
36. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
37. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
38. Mast cell population in the development of diabetic nephropathy: Effects of renin angiotensin system inhibition.
de Morais RB; do Couto Muniz VP; Nunes Costa E; Filho SRF; Nakamura Hiraki KR; Bispo-da-Silva LB; Coelho Balbi AP
Biomed Pharmacother; 2018 Nov; 107():1115-1118. PubMed ID: 30257323
[TBL] [Abstract][Full Text] [Related]
39. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
[TBL] [Abstract][Full Text] [Related]
40. Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
Malek V; Sharma N; Sankrityayan H; Gaikwad AB
Life Sci; 2019 Mar; 221():159-167. PubMed ID: 30769114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
